Actualités

We are pleased to announce the excellent results of a prospective observational study showing the safety and effectiveness of the BAGUERA®C cervical disc prosthesis. The device was evaluated 2 years postoperative, based on clinical and radiographical data of 118 patients with symptomatic cervical degenerative disc diseases (SCDDD), treated by total disc replacement (TDR) using the BAGUERA®C prosthesis. This study was conducted in 5 hospitals or clinics across France, Belgium, Spain, Germany and Greece.

The clinical and radiographical results showed that TDR using the BAGUERA®C device is:
– a safe procedure with low complication rate and no device-related adverse event
– an effective surgical treatment of single or double levels SCDDD, either used alone or in combination with other techniques (hybrid surgeries)

For both techniques (TDR-only and hybrid surgeries) the preservation of mobility and the disc height restoration at the implanted level were demonstrated. These results will be presented during the 2014 NASS meeting in San Francisco in November.

San Francisco, USA. Spineart is pleased to announce the first implantation of its lateral interbody device JULIET® LL in combination with the OTELO® MIS LATERAL Retractor.

Spineart has reached a new milestone, entering into the lateral approach market with an innovative full carbon fiber retractor that allows complete visualisation of the surgical site thanks to its radiolucent characteristics.

Dr Dimitriy Kondrashov, MD successfully performed the first case worldwide at St Mary Hospital in San Francisco. After the case, Dr Kondrashov commented: « The radiolucent design has allowed unparalleled visualization of the disk space and the placement of both the trials as well as the final implant under lateral fluoroscopic view. It made a very challenging multilevel degenerative scoliosis case safer and more straightforward. Being able to see the exact trial position has allowed me to avoid endplate violation and optimize anterior-to-posterior placement of the final lateral cages. I am looking forward to my next lateral case ».

All Spineart implants are sterile packaged and bar-coded for increased safety, traceability and cost-efficiency.

For more information, please contact us at contact@spineart.com9

In mid-march, the Spineart Academy in co-operation with GE Healthcare hosted an advanced training course on Motion, M.I.S. and Deformity technologies at the University of Hamburg, Germany. 20 participants from Chile, France, Spain, Portugal, Italy, Iran, Poland and the Kingdom of Bahrain had the opportunity to learn more about the latest innovations in total cervical disc replacement, management of adult scoliosis and minimally invasive treatment methods. During dedicated wet-lab sessions, all participants had the opportunity to train on M.I.S. surgical techniques through hands-on anatomical workshops. Thanks to prominent surgeon faculty from Belgium, France, and Germany, it was a successful and informative course!

Earlier this month Spineart hosted a lab in Las Vegas, Nevada where 33 participants from the USA, Australia, Brazil, Mexico, and Colombia had the opportunity to learn more about the latest innovations in total cervical disc replacement, management of adult scoliosis and minimally invasive treatment methods for degenerative conditions.

All participants had the opportunity to train on M.I.S. surgical techniques through interactive presentations and hands-on anatomical workshops. Thanks to prominent surgeon faculty from the USA, Colombia and France, it was a successful and informative course!

Spineart Academy in San Diego, USA

Last week Spineart hosted a lab in San Diego where 40 participants from the USA, Brazil, Mexico, Colombia and Taiwan had the opportunity to learn more about the latest innovations in total cervical disc replacement, management of adult scoliosis and minimally invasive treatment methods for degenerative conditions.

All participants had the opportunity to train on M.I.S. surgical techniques through interactive presentations and hands-on anatomical workshops. Thanks to prominent surgeon faculty from the USA, Mexico and Spain, it was a successful and informative course!

Spineart is pleased to announce that, as of the 1st of November 2013, more than 10’000 BAGUERA® C have been implanted successfully worldwide. The first surgery was held in France in January 2007.

The success of the BAGUERA® C can be attributed to its main key features such as its anatomical shape, easy insertion, shock-absorption, guided mobile PE nucleus and MRI compatibility. All Spineart implants are sterile packed and bar-coded for increased safety, procedure compliance and cost-efficiency.

This implant is not available in the US. For more information, please contact us at contact@spineart.com